Syneron Smoothes Premarket Bumps With 510(k) Clearance
This article was originally published in The Gray Sheet
Syneron Medical's VelaSmooth cellulite treatment system earned 510(k) clearance on June 13 under a new category under the surgical laser product code
You may also be interested in...
Syneron Medical estimates that its non-invasive VelaSmooth cellulite treatment system could be on the U.S. market as early as the third quarter of 2005
Cilta-cel maintained high response rates in longer-term multiple myeloma data, but ide-cel causes less cytokine release syndrome and severe neurotoxicity – and it has a March decision date at the US FDA.
Our updated graphic tracker of key developments from the leading vaccine candidates.